AQR Capital Management
INBX icon

AQR Capital Management’s Inhibrx INBX Stock Holding History

AQR Capital Management’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$563K Buy
8,380
+879
+12% +$65.2K ﹤0.01% 3065
2025
Q4 		$593K Buy
7,501
+1,503
+25% +$102K ﹤0.01% 2823
2025
Q3 		$202K Buy
+5,998
New +$148K ﹤0.01% 3254
2024
Q4 		– Sell
-13,012
Closed -$204K – 2904
2024
Q3 		$204K Buy
+13,012
New +$183K ﹤0.01% 2560

Other funds holding INBX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

AQR Capital Management's INBX Position: Q1 2026 in Review

AQR Capital Management increased its Inhibrx (INBX) stake by 12% in Q1 2026, buying an estimated $65.2K and bringing the position to 8,380 shares worth $563K. The position accounts for ﹤0.01% of the portfolio, ranked #3065.

AQR Capital Management first reported a position in INBX in Q3 2024 and has held it in 4 quarters since. The position peaked at $593K in Q4 2025. 135 funds tracked by Wall St. Rank hold INBX as of Q1 2026.

  • AQR Capital Management held 8,380 shares of Inhibrx worth $563K as of Q1 2026.
  • AQR Capital Management bought 879 Inhibrx shares in Q1 2026, an estimated $65.2K.
  • Inhibrx made up ﹤0.01% of AQR Capital Management's portfolio in Q1 2026, its #3065 holding.
  • AQR Capital Management first reported a position in Inhibrx in Q3 2024 and has held it in 4 quarters since.
  • AQR Capital Management's Inhibrx position peaked at $593K in Q4 2025.
  • 135 funds tracked by Wall St. Rank held Inhibrx as of Q1 2026.

Based on AQR Capital Management's 13F filing for Q1 2026, filed 15 May 2026.